Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21826 AL 21840

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection

Chiang MC, Yang YP, Nicol CJB, Wang CJ.

Int J Mol Sci. 2024 Feb 17;25(4):2360. doi: 10.3390/ijms25042360.

Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases

Iyer S, Bhat I, Bangera Sheshappa M.

Mol Nutr Food Res. 2024 Jul;68(13):e2300409. doi: 10.1002/mnfr.202300409. Epub 2024 Mar 15.

Biomarkers for Managing Neurodegenerative Diseases

Cheslow L, Snook AE, Waldman SA.

Biomolecules. 2024 Mar 26;14(4):398. doi: 10.3390/biom14040398.

Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease

Li Y, Zhang J, Ma B, Yu W, Xu M, Luan W, Yu Q, Zhang L, Rong R, Fu Y, Cao H.

Int J Pharm. 2024 Dec 5;666:124786. doi: 10.1016/j.ijpharm.2024.124786. Epub 2024 Oct 6.

Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's Disease, Parkinson's Disease, and stroke

Zhou W, Wang X, Dong Y, Gao P, Zhao X, Wang M, Wu X, Shen J, Zhang X, Lu Z, An W.

Theranostics. 2024 May 27;14(8):3358-3384. doi: 10.7150/thno.95953. eCollection 2024.

Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies

Cehlar O, Njemoga S, Horvath M, Cizmazia E, Bednarikova Z, Barrera EE.

Int J Mol Sci. 2024 Dec 4;25(23):13049. doi: 10.3390/ijms252313049.

Physical exercise-mediated neuroprotective mechanisms in Parkinson's disease, Alzheimer's disease, and epilepsy

Pinho RA, Muller AP, Marqueze LF, Radak Z, Arida RM.

Braz J Med Biol Res. 2024 Nov 25;57:e14094. doi: 10.1590/1414-431X2024e14094. eCollection 2024.

Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review

Bansal K, Singh V, Singh S, Mishra S.

Curr Mol Med. 2024;24(3):316-326. doi: 10.2174/1566524023666230320144722.

Proteomic-Based Studies on Memory Formation in Normal and Neurodegenerative Disease-Affected Brains

da Silva Beraldo IJ, Prates Rodrigues M, Polanczyk RS, Verano-Braga T, Lopes-Aguiar C.

Adv Exp Med Biol. 2024;1443:129-158. doi: 10.1007/978-3-031-50624-6_7.

A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease

Ghosh N, Sinha K, Sil PC.

Basic Clin Pharmacol Toxicol. 2024 May;134(5):602-613. doi: 10.1111/bcpt.14003. Epub 2024 Mar 14.

[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment]

Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F.

Nervenarzt. 2024 Apr;95(4):362-367. doi: 10.1007/s00115-023-01577-2. Epub 2023 Dec 14.

Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases

Balestri W, Sharma R, da Silva VA, Bobotis BC, Curle AJ, Kothakota V, Kalantarnia F, Hangad MV, Hoorfar M, Jones JL, Tremblay MÈ, El-Jawhari JJ, Willerth SM, Reinwald Y.

J Neuroinflammation. 2024 Jan 23;21(1):32. doi: 10.1186/s12974-024-03024-8.

14-3-3 protein and its isoforms: A common diagnostic marker for Alzheimer's disease, Parkinson's disease and glaucomatous neurodegeneration

Panda SP, Kesharwani A, Singh B, Marisetti AL, Chaitanya M, Dahiya S, Ponnusankar S, Kumar S, Singh M, Shakya PK, Prasad PD, Guru A.

Ageing Res Rev. 2024 Dec;102:102572. doi: 10.1016/j.arr.2024.102572. Epub 2024 Nov 1.

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach

So YJ, Lee JU, Yang GS, Yang G, Kim SW, Lee JH, Kim JU.

Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias